BrainStorm Granted Additional Patent for NurOwn® in Israel – Nasdaq

BrainStorm Granted Additional Patent for NurOwn® in Israel  Nasdaq

NEW YORK, Jan. 22, 2019– BrainStorm Cell Therapeutics Inc., a leader in developing innovative autologous cellular therapies for debilitating.